National Health Investors, Inc.

NHI Real Estate Reit Healthcare Facilities

National Health Investors, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $375.6 million, up 12.1% from fiscal 2024. In the quarter to June 2026, revenue grew 33.8%, EPS grew 45.6%, free cash flow grew 2,585.5% and total debt rose 13.9%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for three; insiders bought in the last twelve months.

66.28 0.61 +0.93%
Market cap
$3.2B
P/E
19.1×
Fwd P/E
20.2×
Dividend yield
5.58%
F-score
5/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

National Health Investors, Inc. (NHI) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, National Health Investors, Inc. (NHI) trades at a EV/Sales of 10.3×. Over the past ten years it has ranged from 9.1× (March 2020) to 19.2× (January 2015); the current reading is higher than 1% of that period. That is above the Reit Healthcare Facilities industry median of 8.5× and above the Real Estate sector median of 7.6×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 12.6× 1.33%
FY2024 12.4× 12.52%
FY2023 11.0× (12.16%)
FY2022 12.6× (2.12%)
FY2021 12.8× (6.10%)
FY2020 13.7× (12.60%)
FY2019 15.6× 3.61%
FY2018 15.1× (0.86%)
FY2017 15.2× (5.94%)
FY2016 16.2× 16.13%

Quarterly newest first

Period EV/Sales Change
Jun 2026 11.4× (10.96%)
Mar 2026 12.8× 2.05%
Dec 2025 12.6× (6.81%)
Sep 2025 13.5× 7.57%
42 more quarters

Against its own ten years

Low 9.1× High 19.2×
Ten-year median 13.8×
Current reading's percentile 1

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on NHI